Ottosson A L, Jansen I, Langemark M, Olesen J, Edvinsson L
Department of Forensic Medicine, University of Lund, Sweden.
Cephalalgia. 1991 Sep;11(4):183-8. doi: 10.1046/j.1468-2982.1991.1104183.x.
The subtypes of histamine receptors mediating dilatation of human meningeal arteries have been tested in vitro, using "selective" antagonists, and compared with cerebral and temporal arteries previously examined. Dilatory responses were tested after preconstriction with prostaglandin F2 alpha. Both mepyramine and cimetidine caused a parallel shift to the right of the histamine concentration-response curve, suggesting the presence of both H1- and H2-receptors. Combined treatment with mepyramine and cimetidine caused further displacement of the concentration-response curve to the right. Schild analysis indicated pA2 values of 6.3 for cimetidine and 9.8 for mepyramine in situations of near complete blockade of either of the receptors. Both H1- and H2-receptors seem of importance for the histamine-induced dilatation in meningeal arteries and neither appear to dominate. The data considered in conjunction with our previous findings support the finding that experimental histamine-induced headache due to vasodilatation is intracranial of origin.
利用“选择性”拮抗剂在体外对介导人脑膜动脉扩张的组胺受体亚型进行了测试,并与之前检测过的脑动脉和颞动脉进行了比较。在用前列腺素F2α预收缩后测试扩张反应。美吡拉敏和西咪替丁均使组胺浓度-反应曲线平行右移,提示同时存在H1和H2受体。美吡拉敏和西咪替丁联合治疗使浓度-反应曲线进一步右移。Schild分析表明,在任一受体接近完全阻断的情况下,西咪替丁的pA2值为6.3,美吡拉敏的pA2值为9.8。H1和H2受体似乎对组胺诱导的脑膜动脉扩张均很重要,且两者均未占主导地位。结合我们之前的研究结果来看,这些数据支持以下发现:实验性组胺诱导的因血管扩张引起的头痛起源于颅内。